NEUROPROTECTIVE EFFECT OF PAROXETINE HYDROCHLORIDE AMONG 781 CANCER PATIENTS RECEIVING CHEMOTHERAPY: A URCC CCOP STUDY. Pascal Jean-Pierre, PhD, MPH University.
